Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Cancer Survival Analysis01:21

Cancer Survival Analysis

645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Cancer Prevention02:59

Cancer Prevention

7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Perspectives From an Expert-Guided Discussion on Maximizing the Research Potential of Small Biopsy Tissue.

JCO precision oncology·2026
Same author

Advancing Guideline Methodology in Interventional Radiology: Introduction of the Clinical Care Recommendation Framework.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Irreversible Electroporation of Spine Tumors in a Canine Model: Tumoricidal Effects and Neural Toxicity.

Journal of vascular and interventional radiology : JVIR·2026
Same author

A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind.

Molecular systems biology·2026
Same author

The ADAPT learning cancer treatment system: ARPA-H's initiative to revolutionize cancer therapy.

Cancer cell·2026
Same author

Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapy.

NPJ precision oncology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 13, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.6K

Marco para la perfilación e intercepción de la evolución del cáncer en el cáncer colorrectal: programa ASCEND-CRC

Salvador Alonso1, Kanwal Raghav1, Van K Morris1

  • 1Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, USA.

Cancer cell
|January 9, 2026
PubMed
Resumen

Este estudio presenta un nuevo enfoque para el tratamiento del cáncer mediante el seguimiento de la evolución tumoral en tiempo real. Su objetivo es identificar biomarcadores dinámicos para personalizar las terapias y superar la resistencia al tratamiento en el cáncer colorrectal metastásico.

Palabras clave:
cáncer colorrectalevolución tumoralresistencia al tratamientobiomarcadores dinámicosmedicina de precisiónoncología traslacional

Más Videos Relacionados

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

14.3K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.9K

Videos de Experimentos Relacionados

Last Updated: Jan 13, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.6K
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

14.3K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.9K

Área de la Ciencia:

  • Oncología
  • Medicina Traslacional
  • Biología del Cáncer

Sus antecedentes:

  • La evolución del cáncer es dinámica, pero los tratamientos suelen ser estáticos, lo que conduce a la resistencia.
  • El muestreo tumoral limitado dificulta la comprensión de los estados adaptativos que preceden a la resistencia.
  • El programa ADAPT de ARPA-H tiene como objetivo alinear las terapias contra el cáncer con la evolución tumoral en tiempo real.

Objetivo del estudio:

  • Descubrir mecanismos adaptativos tempranos en el cáncer colorrectal (CCR) metastásico.
  • Identificar biomarcadores dinámicos para guiar la toma de decisiones terapéuticas.
  • Establecer una plataforma escalable para interceptar la resistencia al cáncer.

Principales métodos:

  • El ensayo ASCEND-CRC integra la perfilación multimodal.
  • Se emplea el seguimiento longitudinal de la evolución tumoral.
  • Enfoque en biomarcadores dinámicos más allá de los marcadores únicos previos al tratamiento.

Principales resultados:

  • Se están investigando mecanismos adaptativos tempranos que preceden a la resistencia.
  • Se está definiendo un conjunto de biomarcadores dinámicos para informar las decisiones de tratamiento.
  • El estudio está estableciendo un marco para ajustes terapéuticos en tiempo real.

Conclusiones:

  • El ensayo ASCEND-CRC representa un cambio de paradigma en la oncología de precisión.
  • Esta iniciativa tiene como objetivo transformar la atención del cáncer mediante la intercepción de la resistencia.
  • La perfilación multimodal longitudinal es clave para la terapia personalizada contra el cáncer.